Dr. Jessica Wilcox, MD (Chief Fellow, Class of 2021), and her mentor Dr. Adrienne Boire, MD PhD, discussing their first-in-human clinical trial in development for patients with leptomeningeal metastases.
Our fellows receive training in clinical research methodology through the NIH-funded Clinical Research and Methodology Curriculum (CRMC). Fellows are also encouraged to participate in longitudinal Protocol Writing and Biostatistics courses.
Throughout training, fellows serve as departmental protocol reviewers—gaining experience in the critical thinking skills required for investigator-initiated study design. They have the opportunity to pair with a faculty mentor to execute a longitudinal basic, translational, or clinical research project.
MSK offers access to some of the top clinical investigators in the field of neuro-oncology. Our fellowship also has a strong track record of producing translational and bench research scientists at the world-renowned MSKC research laboratories. Applicants interested in pursuing bench research are encouraged to contact Julia Malcolm ([email protected]) for more information.
Approximately 20 weeks of elective time may be dedicated to research in the first year of fellowship, with an additional 40 weeks in the second year of the fellowship.
Additional Information
Our fellows are given the opportunity to attend and present at national meetings such as the Society for Neuro-Oncology, American Academy of Neurology, American Society of Clinical Oncology, and American Society of Hematology. Participation at these meetings is strongly encouraged. Examples of fellow presentations are below.
Our fellows are supported by intramural funding sources, but as part of the training process they are provided with the tools necessary to apply for extramural sources of funding to support their career development. Those interested in pursuing funding for a basic or translational science project may apply for a two-year K12 training grant.
Recent Presentations in National Meetings
Abstract Title: “Reversible Parkinsonism After BCMA-directed CAR T cell Administration”
Presenter: Alexandra Gewirtz, MD
Mentor: Bianca Santomasso, MD
Society for Neuro-Oncology 2023 Meeting
Abstract Title: “Illness Understanding and Religiousness in Patients with Recurrent Glioblastoma”
Presenter: John Fortunato, MD
Mentor: Eli Diamond, MD
Society for Neuro-Oncology 2023 Meeting
Abstract Title: “Results of safety lead in of phase II trial of combination olaparib, temozolomide and pembrolizumab for patients with IDH-mutant glioma”
Presenter: John Fortunato, MD
Mentor: Lauren Schaff, MD
Society for Neuro-Oncology 2023 Meeting
Abstract Title: “A Case of Widespread Extracranial Metastases from a Gliosarcoma”
Presenter: Maliheh Mohamadpour, MD
Mentor: Joshua Budhu, MD
Society for Neuro-Oncology 2023 Meeting
rAbstract Title: “A Phase II Study of Lenvatinib Plus Pembrolizumab in Patients with Progressive, Recurrent/Metastatic Adenoid Cystic Carcinoma”
Presenter: Maliheh Mohamadpour, MD
Mentor: Alan Ho, MD
American Society of Clinical Oncology 2023 Meeting
Abstract Title: “Neurotoxicity after a single cycle of intravenous cytarabine”
Presenter: John Herbst, DO
Mentor: Lauren Schaff, MD
Society for Neuro-Oncology 2022 Meeting
Abstract Title: “Non-invasive diagnosis of IDH-mutant brainstem gliomas”
Presenter: Marina Kushnirsky, MD
Mentor: Andrew Lin, MD
Society for Neuro-Oncology 2022 Meeting
Recent Fellow Research Awards
Fellow: Elizabeth Coffee, awarded training grant during fellowship
Mentor: Kayvan Keshari, Ingo Mellinghoff
Project Title: Hyperpolarized dehydroascorbate (HP DHA) to quantify oxidative stress and its role in the radioresistance of glioblastoma
Source: The Tow Foundation Postdoctoral Fellowship, Center for Molecular Imaging and Nanotechnology
Fellow: Jessica Wilcox, awarded training grant during fellowship
Mentor: Adrienne Boire
Project Title: Phase 1a/1b Trial to Assess Safety and Bioactivity of Intrathecal Deferoxamine in Patients with Leptomeningeal Metastases from Non-Small Cell Lung Cancer
Source: ASCO 2021 Conquer Cancer Young Investigator Award
Fellow: Ivan Kotchetkov, awarded training grant during fellowship
Mentor: Michel Sadelain
Project Title: Development of ANTXR1 Targeting CAR T cells in Glioblastoma
Source: T32 Training Award, Memorial Sloan Kettering Cancer Center
Fellow: Maya Graham, awarded training grant during fellowship
Mentor: Ingo Mellinghoff
Project Title: Dissecting Epigenomic Reprogramming Mediated by Oncohistones in Pediatric High-Grade Glioma Using Human Cerebral Organoids
Source: T32 Training Award, Memorial Sloan Kettering Cancer Center
Fellow: Rebecca Brown, awarded training grant during fellowship
Mentor: Luis Parada
Project Title: Malignant Conversion of Benign Plexiform Neurofibromas in NF1: Role of a Pre-Cancerous Stem Cell-Like Population
Source: T32 Training Award, Memorial Sloan Kettering Cancer Center
More information
Contact
Julia Malcolm, MPA
GME Coordinator III
Memorial Sloan Kettering Cancer Center
Department of Neurology
1275 York Avenue, 7th Floor
New York, NY 10065
[email protected]